메뉴 건너뛰기




Volumn 405, Issue 1-2, 2011, Pages 9-15

Plume temperature emitted from metered dose inhalers

Author keywords

Aerosol; HFAs; Hydrofluoroalkane; Plume temperature; Pressurised metered dose inhaler

Indexed keywords

ALCOHOL; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CHLOROFLUOROCARBON; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; FORMOTEROL; PLACEBO; SALBUTAMOL;

EID: 79151477608     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.11.037     Document Type: Article
Times cited : (30)

References (12)
  • 1
    • 34248639855 scopus 로고    scopus 로고
    • The rejuvenated pressurised metered dose inhaler
    • J. Bell, and S. Newman The rejuvenated pressurised metered dose inhaler Expert Opin. 4 2007 215 234
    • (2007) Expert Opin. , vol.4 , pp. 215-234
    • Bell, J.1    Newman, S.2
  • 5
    • 0004341743 scopus 로고
    • Problems patients have using pressurised aerosol inhalers
    • G. Crompton Problems patients have using pressurised aerosol inhalers Eur. J. Respir. Dis. Suppl. 119 1982 57 65
    • (1982) Eur. J. Respir. Dis. Suppl. , vol.119 , pp. 57-65
    • Crompton, G.1
  • 6
    • 0032764740 scopus 로고    scopus 로고
    • A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers
    • B.J. Gabrio, S.W. Stein, and D.J. Velasquez A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers Int. J. Pharm. 186 1999 3 12
    • (1999) Int. J. Pharm. , vol.186 , pp. 3-12
    • Gabrio, B.J.1    Stein, S.W.2    Velasquez, D.J.3
  • 8
    • 0346758138 scopus 로고    scopus 로고
    • The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler
    • D. Ganderton, D. Lewis, R. Davies, B. Meakin, G. Brambilla, and T. Church The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler Respir. Med. 97 Suppl. D 2003 S4 S9
    • (2003) Respir. Med. , vol.97 , Issue.SUPPL. D
    • Ganderton, D.1    Lewis, D.2    Davies, R.3    Meakin, B.4    Brambilla, G.5    Church, T.6
  • 10
    • 34248669337 scopus 로고    scopus 로고
    • New actuators versus old: Reasons and results for actuator modifications for HFA solution MDIs
    • D.A. Lewis, B.J. Meakin, and G. Brambilla New actuators versus old: reasons and results for actuator modifications for HFA solution MDIs R.N. Dalby, P.R. Byron, J. Peart, J.D. Suman, S.J. Farr, Respiratory Drug Delivery X 2006 Davis Healthcare International Publishing Rivergrove, IL 101 110 Book 1
    • (2006) Respiratory Drug Delivery X , pp. 101-110
    • Lewis, D.A.1    Meakin, B.J.2    Brambilla, G.3
  • 11
    • 0012641122 scopus 로고    scopus 로고
    • Countering challenges posed by mimicry of CFC performance using HFA systems
    • B.J. Meakin, D.A. Lewis, D. Ganderton, and G. Brambilla Countering challenges posed by mimicry of CFC performance using HFA systems R.N. Dalby, P.R. Byron, S.J. Farr, J. Peart, Respiratory Drug Delivery VII vol. 1 2000 Serentec Press Inc. Raleigh, NC 99 107
    • (2000) Respiratory Drug Delivery VII , vol.1 , pp. 99-107
    • Meakin, B.J.1    Lewis, D.A.2    Ganderton, D.3    Brambilla, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.